1
|
Gutierrez-Tobar I, Carvajal C, Vasquez-Hoyos P, Díaz-Díaz A, Londono Ruiz JP, Andrade J, Camacho-Cruz J, Restrepo-Gouzy A, Trujillo-Honeysberg M, Mesa-Monsalve JG, Perez I, Von Moltke R, Beltran-Echeverry M, Toro JF, Niño AP, Camacho-Moreno G, Calle-Giraldo JP, Cabeza NY, Sandoval-Calle LM, Perez Camacho P, Patiño Niño J, Araque-Muñoz P, Rodríguez-Peña Y, Beltran-Arroyave C, Chaucanez-Bastidas Y, Lopez J, Galvis-Trujillo D, Beltrán-Higuera S, Marino AC, González Leal N, Luengas Monroy MÁ, Hernandez-Moreno DC, Vivas Trochez R, Garces C, López-Medina E. Epidemiological and microbiological characteristics of S. aureus pediatric infections in Colombia 2018-2021, a national multicenter study (Staphylored Colombia). Front Pediatr 2024; 12:1386310. [PMID: 38895192 PMCID: PMC11183781 DOI: 10.3389/fped.2024.1386310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2024] [Accepted: 05/13/2024] [Indexed: 06/21/2024] Open
Abstract
Background Staphylococcus aureus infections are a significant cause of morbidity and mortality in pediatric populations worldwide. The Staphylo Research Network conducted an extensive study on pediatric patients across Colombia from 2018 to 2021. The aim of this study was to describe the epidemiological and microbiological characteristics of S. aureus in this patient group. Methods We analyzed S. aureus isolates from WHONET-reporting centers. An "event" was a positive culture isolation in a previously negative individual after 2 weeks. We studied center characteristics, age distribution, infection type, and antibiotic susceptibilities, comparing methicillin sensitive (MSSA) and resistant S. aureus (MRSA) isolates. Results Isolates from 20 centers across 7 Colombian cities were included. Most centers (80%) served both adults and children, with 55% offering oncology services and 85% having a PICU. We registered 8,157 S. aureus culture isolations from 5,384 events (3,345 MSSA and 1,961 MRSA) in 4,821 patients, with a median age of 5 years. Blood (26.2%) and skin/soft tissue (18.6%) were the most common infection sources. Most isolates per event remained susceptible to oxacillin (63.2%), clindamycin (94.3%), and TMP-SMX (98.3%). MRSA prevalence varied by city (<0.001), with slightly higher rates observed in exclusively pediatric hospitals. In contrast, the MRSA rate was somewhat lower in centers with Antimicrobial Stewardship Program (ASP). MRSA was predominantly isolated from osteoarticular infections and multiple foci, while MSSA was more frequently associated with recurrent infections compared to MRSA. Conclusions This is the largest study of pediatric S. aureus infections in Colombia. We found MSSA predominance, but resistance have important regional variations. S. aureus remains susceptible to other commonly used antibiotics such as TMP-SMX and clindamycin. Ongoing monitoring of S. aureus infections is vital for understanding their behavior in children. Prospective studies within the Staphylored LATAM are underway for a more comprehensive clinical and genetic characterization.
Collapse
Affiliation(s)
- Ivan Gutierrez-Tobar
- Department of Pediatrics, Clínica Infantil Santa Maria Del Lago, Bogotá, Colombia
- Department of Pediatrics, Clinica Infantil Colsubsidio, Bogotá, Colombia
- Staphylored LATAM, Bogotá, Colombia
| | - Cristobal Carvajal
- Staphylored LATAM, Bogotá, Colombia
- Universidad Finis Terrae, Santiago, Chile
| | - Pablo Vasquez-Hoyos
- Staphylored LATAM, Bogotá, Colombia
- Department of Pediatrics, Fundacion Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia
- Universidad Nacional de Colombia, Bogotá, Colombia
- Sociedad de Cirugía de Bogotá Hospital de San Jose, Bogotá, Colombia
| | - Alejandro Díaz-Díaz
- Staphylored LATAM, Bogotá, Colombia
- Department of Pediatrics, Hospital Pablo Tobon Uribe, Medellín, Colombia
- Department of Pediatrics, Hospital General de Medellín, Medellín, Colombia
| | - Juan Pablo Londono Ruiz
- Department of Pediatrics, Clinica Infantil Colsubsidio, Bogotá, Colombia
- Staphylored LATAM, Bogotá, Colombia
| | - Joam Andrade
- Staphylored LATAM, Bogotá, Colombia
- Department of Pediatrics, Hospital Militar Central, Bogotá, Colombia
| | - Jhon Camacho-Cruz
- Staphylored LATAM, Bogotá, Colombia
- Department of Pediatrics, Fundacion Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia
- Universidad Nacional de Colombia, Bogotá, Colombia
- Sociedad de Cirugía de Bogotá Hospital de San Jose, Bogotá, Colombia
- Department of Pediatrics, Fundación Universitaria Sanitas, Bogotá, Colombia
- Department of Pediatrics, Clínica Reina Sofia Pediátrica y Mujer, Bogotá, Colombia
| | | | | | | | | | - Richard Von Moltke
- Staphylored LATAM, Bogotá, Colombia
- Universidad Finis Terrae, Santiago, Chile
| | - Maria Beltran-Echeverry
- Department of Pediatrics, Clínica Infantil Santa Maria Del Lago, Bogotá, Colombia
- Staphylored LATAM, Bogotá, Colombia
- Sociedad de Cirugía de Bogotá Hospital de San Jose, Bogotá, Colombia
| | - Jessica F. Toro
- Department of Pediatrics, Clínica Medilaser, Neiva, Colombia
| | - Angela P. Niño
- Department of Pediatrics, Clínica Medilaser, Neiva, Colombia
| | - Germán Camacho-Moreno
- Department of Pediatrics, Fundación Hospital de La Misericordia, Bogotá, Colombia
- Department of Pediatrics, Hospital Universitario Infantil de San José, Bogotá, Colombia
| | - Juan Pablo Calle-Giraldo
- Department of Pediatrics, Hospital San Juan de Dios, Armenia, Colombia
- Department of Pediatrics, Clinica Farallones, Cali, Colombia
- Department of Pediatrics, Clinica Versalles, Cali, Colombia
| | | | | | | | | | - Paula Araque-Muñoz
- Department of Pediatrics, Clinica Country, Bogotá, Colombia
- Department of Pediatrics, Clinica La Colina, Bogotá, Colombia
| | - Yazmin Rodríguez-Peña
- Department of Pediatrics, Clinica Country, Bogotá, Colombia
- Department of Pediatrics, Clinica La Colina, Bogotá, Colombia
| | | | | | - Juan Lopez
- Department of Pediatrics, Fundación Hospital de La Misericordia, Bogotá, Colombia
| | | | - Sandra Beltrán-Higuera
- Clinica Colsanitas, Bogotá, Colombia
- Department of Pediatrics, Clinica infantil Colsanitas, Bogotá, Colombia
| | | | | | | | | | - Rosalba Vivas Trochez
- Department of Pediatrics, Clínica Soma, Medellín, Colombia
- Department of Pediatrics, Hospital Universitario de San Vicente Fundación, Medellín, Colombia
| | - Carlos Garces
- Department of Pediatrics, Clinica Cardiovid Medellín, Medellin, Colombia
| | - Eduardo López-Medina
- Centro de Estudios en Infectología Pediátrica, Cali, Colombia
- Universidad del Valle, Cali, Colombia
- Department of Pediatrics, Clínica Imbanaco, Cali, Colombia
| |
Collapse
|
2
|
Barcudi D, Blasko E, Gonzalez MJ, Gagetti P, Lamberghini R, Garnero A, Sarkis C, Faccone D, Lucero C, Tosoroni D, Study Group of S. aureus in Argentina, Bocco JL, Corso A, Sola C. Different evolution of S. aureus methicillin-resistant and methicillin-susceptible infections, Argentina. Heliyon 2024; 10:e22610. [PMID: 38163174 PMCID: PMC10755277 DOI: 10.1016/j.heliyon.2023.e22610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 11/14/2023] [Accepted: 11/15/2023] [Indexed: 01/03/2024] Open
Abstract
Staphylococcus aureus-(SA) is widespread among healthcare-associated-(HA) and the community-associated-(CA) infections. However, the contributions of MRSA and MSSA to the SA overall burden remain unclear. In a nationally-representative-survey conducted in Argentina, 668 SA clinical isolates from 61 hospitals were examined in a prospective, cross-sectional, multicenter study in April 2015. The study aimed to analyze MRSA molecular epidemiology, estimate overall SA infection incidence (MSSA, MRSA, and genotypes) in community-onset (CO: HACO, Healthcare-Associated-CO and CACO, Community-Associated-CO) and healthcare-onset (HO: HAHO, Healthcare-associated-HO) infections, stratified by age groups. Additionally temporal evolution was estimated by comparing this study's (2015) incidence values with a previous study (2009) in the same region. Erythromycin-resistant-MSSA and all MRSA strains were genetically typed. The SA total-infections (TI) overall-incidence was 49.1/100,000 monthly-visits, 25.1 and 24.0 for MRSA and MSSA respectively (P = 0.5889), in April 2015. In adults with invasive-infections (INVI), MSSA was 15.7 and MRSA was 11.8 (P = 0.0288), 1.3-fold higher. HA SA infections, both MSSA and MRSA, surpassed CA infections by over threefold. During 2009-2015, there was a significant 23.4 % increase in the SA infections overall-incidence, mainly driven by MSSA, notably a 54.2 % increase in INVI among adults, while MRSA infection rates remained stable. The MSSA rise was accompanied by increased antimicrobial resistance, particularly to erythromycin, linked to MSSA-CC398-t1451-ermT + -IEC+-pvl- emergence. The SA-infections rise was primarily attributed to community-onset-infections (37.3 % and 62.4 % increase for TI and INVI, respectively), particularly HACO-MSSA and HACO-MRSA in adults, as well as CACO-MSSA. The main CA-MRSA-PFGE-typeN-ST30-SCCmecIVc-PVL+/- clone along with other clones (USA300-ST8-IV-LV-PVL+/-, PFGE-typeDD-ST97-IV- PVL-) added to rather than replaced CA-MRSA-PFGE-typeI-ST5-SCCmecIVa-PVL+/- clone in HA invasive-infections. They also displaced clone HA-MRSA-PFGE-typeA-ST5-SCCmecI, mainly in HAHO infections. The overall-burden of SA infections is rising in Argentina, driven primarily by community-onset MSSA, particularly in adults, linked to increased erythromycin-resistance and MSSA-CC398-t1451-ermT + -IEC+-pvl- emergence. Novel knowledge and transmission-control strategies are required for MSSA.
Collapse
Affiliation(s)
- Danilo Barcudi
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI) CONICET and Universidad Nacional de Córdoba, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Haya de La Torre y Medina Allende, Ciudad Universitaria, X5000, Córdoba, Argentina
| | - Enrique Blasko
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI) CONICET and Universidad Nacional de Córdoba, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Haya de La Torre y Medina Allende, Ciudad Universitaria, X5000, Córdoba, Argentina
| | - María José Gonzalez
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI) CONICET and Universidad Nacional de Córdoba, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Haya de La Torre y Medina Allende, Ciudad Universitaria, X5000, Córdoba, Argentina
| | - Paula Gagetti
- Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS “Dr. Carlos G. Malbrán”, Ciudad Autónoma de Buenos Aires, Argentina
| | - Ricardo Lamberghini
- Cátedra de Infectología I, Hospital Rawson, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Bajada Pucará 2025, X5000, Córdoba, Argentina
| | - Analía Garnero
- Servicio de Infectología, Hospital de Niños de la Santísima Trinidad de Córdoba, Córdoba, Bajada Pucará 787, X 5000, ANN, Argentina
| | - Claudia Sarkis
- Hospital de Pediatría S.A.M.I.C."Prof. Dr. Juan P. Garrahan”, Combate de los Pozos 1881, C1245, AAM, CABA, Argentina
| | - Diego Faccone
- Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS “Dr. Carlos G. Malbrán”, Ciudad Autónoma de Buenos Aires, Argentina
| | - Celeste Lucero
- Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS “Dr. Carlos G. Malbrán”, Ciudad Autónoma de Buenos Aires, Argentina
| | - Dario Tosoroni
- Informática Médica, Facultad de Medicina, Universidad Católica de Córdoba, Jacinto Ríos 555, X5004, ASK, Córdoba, Argentina
| | | | - José L. Bocco
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI) CONICET and Universidad Nacional de Córdoba, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Haya de La Torre y Medina Allende, Ciudad Universitaria, X5000, Córdoba, Argentina
| | - Alejandra Corso
- Servicio Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS “Dr. Carlos G. Malbrán”, Ciudad Autónoma de Buenos Aires, Argentina
| | - Claudia Sola
- Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI) CONICET and Universidad Nacional de Córdoba, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Haya de La Torre y Medina Allende, Ciudad Universitaria, X5000, Córdoba, Argentina
| |
Collapse
|